Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Hip | 53 | 2024 | 1413 | 12.030 |
Why?
|
Arthroplasty, Replacement, Knee | 53 | 2024 | 1393 | 10.920 |
Why?
|
Prosthesis-Related Infections | 28 | 2024 | 488 | 8.550 |
Why?
|
Hip Prosthesis | 17 | 2024 | 921 | 5.720 |
Why?
|
Knee Prosthesis | 12 | 2023 | 395 | 3.610 |
Why?
|
Arthritis, Infectious | 11 | 2023 | 347 | 3.400 |
Why?
|
Osteoarthritis, Knee | 18 | 2024 | 1234 | 2.520 |
Why?
|
Osteoarthritis, Hip | 9 | 2024 | 409 | 2.510 |
Why?
|
Knee Joint | 18 | 2024 | 1676 | 1.940 |
Why?
|
Prosthesis Failure | 10 | 2024 | 1204 | 1.760 |
Why?
|
Osteoarthritis | 7 | 2024 | 1063 | 1.750 |
Why?
|
Prosthesis Design | 11 | 2024 | 2115 | 1.720 |
Why?
|
Synovial Fluid | 9 | 2024 | 393 | 1.560 |
Why?
|
Reoperation | 18 | 2024 | 4303 | 1.200 |
Why?
|
Prescriptions | 2 | 2019 | 386 | 1.030 |
Why?
|
Femur | 11 | 2023 | 1307 | 1.000 |
Why?
|
Arthroplasty | 4 | 2021 | 313 | 0.980 |
Why?
|
Retrospective Studies | 56 | 2024 | 80636 | 0.910 |
Why?
|
Hip Dislocation | 3 | 2022 | 247 | 0.890 |
Why?
|
Orthopedics | 3 | 2022 | 898 | 0.840 |
Why?
|
Polyethylene | 2 | 2023 | 185 | 0.820 |
Why?
|
Femur Head | 1 | 2024 | 297 | 0.810 |
Why?
|
Joint Diseases | 2 | 2018 | 459 | 0.810 |
Why?
|
Pain, Postoperative | 4 | 2019 | 1739 | 0.790 |
Why?
|
Obesity, Morbid | 2 | 2022 | 1277 | 0.690 |
Why?
|
Treatment Outcome | 33 | 2024 | 64680 | 0.610 |
Why?
|
Analgesics, Opioid | 3 | 2019 | 3808 | 0.610 |
Why?
|
Femur Neck | 1 | 2020 | 314 | 0.600 |
Why?
|
Sarcopenia | 1 | 2023 | 372 | 0.590 |
Why?
|
Range of Motion, Articular | 10 | 2023 | 1588 | 0.570 |
Why?
|
Diagnostic Tests, Routine | 2 | 2022 | 787 | 0.540 |
Why?
|
Debridement | 4 | 2022 | 494 | 0.540 |
Why?
|
Hip Joint | 3 | 2018 | 1014 | 0.540 |
Why?
|
Humans | 106 | 2024 | 761504 | 0.540 |
Why?
|
Antiviral Agents | 2 | 2019 | 3060 | 0.530 |
Why?
|
C-Reactive Protein | 6 | 2024 | 3826 | 0.510 |
Why?
|
Personnel Selection | 1 | 2017 | 196 | 0.510 |
Why?
|
Videoconferencing | 1 | 2017 | 203 | 0.500 |
Why?
|
Orthopedic Procedures | 2 | 2021 | 1265 | 0.480 |
Why?
|
Preoperative Care | 3 | 2019 | 2242 | 0.480 |
Why?
|
Device Removal | 1 | 2020 | 630 | 0.480 |
Why?
|
Liver Cirrhosis | 2 | 2015 | 1935 | 0.460 |
Why?
|
Decision Trees | 2 | 2015 | 504 | 0.440 |
Why?
|
Morphine | 1 | 2017 | 657 | 0.430 |
Why?
|
Blood Sedimentation | 3 | 2024 | 235 | 0.420 |
Why?
|
Hyperglycemia | 1 | 2021 | 1376 | 0.420 |
Why?
|
Polyethylenes | 4 | 2024 | 290 | 0.410 |
Why?
|
Depressive Disorder, Major | 2 | 2020 | 4761 | 0.410 |
Why?
|
Rotation | 3 | 2023 | 517 | 0.400 |
Why?
|
Venous Thromboembolism | 2 | 2022 | 1866 | 0.390 |
Why?
|
Postoperative Complications | 7 | 2023 | 15631 | 0.380 |
Why?
|
Postoperative Period | 5 | 2023 | 1813 | 0.380 |
Why?
|
Aged | 31 | 2024 | 169289 | 0.370 |
Why?
|
Erythropoietin | 1 | 2015 | 719 | 0.350 |
Why?
|
Risk Factors | 17 | 2024 | 74206 | 0.350 |
Why?
|
Leukocyte Count | 5 | 2024 | 1596 | 0.350 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 1032 | 0.350 |
Why?
|
Interviews as Topic | 1 | 2017 | 2696 | 0.340 |
Why?
|
Middle Aged | 32 | 2024 | 220895 | 0.340 |
Why?
|
Hepatitis C | 1 | 2019 | 1584 | 0.320 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1117 | 0.320 |
Why?
|
Bupivacaine | 3 | 2024 | 412 | 0.300 |
Why?
|
Posterior Cruciate Ligament | 2 | 2019 | 85 | 0.300 |
Why?
|
Blood Transfusion | 1 | 2015 | 1298 | 0.300 |
Why?
|
Tibia | 6 | 2023 | 1070 | 0.300 |
Why?
|
Models, Theoretical | 1 | 2020 | 3575 | 0.290 |
Why?
|
Length of Stay | 5 | 2021 | 6425 | 0.290 |
Why?
|
Male | 37 | 2024 | 360804 | 0.280 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2007 | 145 | 0.280 |
Why?
|
Patient Transfer | 1 | 2014 | 794 | 0.270 |
Why?
|
Losartan | 1 | 2008 | 265 | 0.270 |
Why?
|
Body Mass Index | 5 | 2024 | 12953 | 0.270 |
Why?
|
Health Care Costs | 3 | 2024 | 3242 | 0.260 |
Why?
|
Weight-Bearing | 3 | 2023 | 532 | 0.250 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39106 | 0.250 |
Why?
|
Female | 34 | 2024 | 392644 | 0.250 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 431 | 0.250 |
Why?
|
Wounds, Penetrating | 1 | 2007 | 313 | 0.240 |
Why?
|
Blood Coagulation | 1 | 2011 | 1154 | 0.240 |
Why?
|
ROC Curve | 3 | 2018 | 3579 | 0.220 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5840 | 0.210 |
Why?
|
Acetabulum | 2 | 2024 | 542 | 0.210 |
Why?
|
Muscle, Skeletal | 2 | 2008 | 4948 | 0.200 |
Why?
|
Staphylococcus | 1 | 2022 | 154 | 0.200 |
Why?
|
Anesthetics, Local | 2 | 2019 | 997 | 0.200 |
Why?
|
Markov Chains | 2 | 2017 | 966 | 0.200 |
Why?
|
Anti-Bacterial Agents | 6 | 2023 | 7407 | 0.190 |
Why?
|
Tendinopathy | 1 | 2024 | 173 | 0.190 |
Why?
|
Decision Support Techniques | 1 | 2011 | 1998 | 0.190 |
Why?
|
Case-Control Studies | 5 | 2023 | 22176 | 0.190 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1303 | 0.190 |
Why?
|
Fibrosis | 1 | 2008 | 2049 | 0.180 |
Why?
|
Epiphyses | 1 | 2021 | 190 | 0.180 |
Why?
|
Drug Users | 1 | 2022 | 134 | 0.180 |
Why?
|
Bone Screws | 1 | 2024 | 532 | 0.180 |
Why?
|
Chicago | 2 | 2011 | 254 | 0.180 |
Why?
|
Patient Satisfaction | 2 | 2023 | 3461 | 0.170 |
Why?
|
Aged, 80 and over | 10 | 2024 | 58976 | 0.170 |
Why?
|
Comorbidity | 3 | 2019 | 10508 | 0.170 |
Why?
|
Sepsis | 1 | 2013 | 2585 | 0.160 |
Why?
|
Arthroplasty, Replacement | 1 | 2022 | 310 | 0.160 |
Why?
|
Spondylitis, Ankylosing | 1 | 2020 | 155 | 0.160 |
Why?
|
Vitamin E | 1 | 2023 | 872 | 0.160 |
Why?
|
Cohort Studies | 7 | 2022 | 41487 | 0.160 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2021 | 467 | 0.150 |
Why?
|
Intra-Abdominal Fat | 1 | 2023 | 613 | 0.150 |
Why?
|
Substance Abuse, Intravenous | 1 | 2022 | 529 | 0.150 |
Why?
|
Genetic Testing | 1 | 2011 | 3537 | 0.150 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 2567 | 0.140 |
Why?
|
Sensitivity and Specificity | 4 | 2024 | 14666 | 0.140 |
Why?
|
Risk Assessment | 4 | 2024 | 23995 | 0.140 |
Why?
|
Episode of Care | 1 | 2017 | 128 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2330 | 0.130 |
Why?
|
Wound Healing | 1 | 2007 | 2805 | 0.130 |
Why?
|
Activities of Daily Living | 2 | 2022 | 2421 | 0.130 |
Why?
|
Anterior Cruciate Ligament | 1 | 2019 | 423 | 0.130 |
Why?
|
Periprosthetic Fractures | 1 | 2016 | 60 | 0.130 |
Why?
|
Interferons | 1 | 2018 | 706 | 0.120 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.120 |
Why?
|
Osseointegration | 1 | 2016 | 274 | 0.120 |
Why?
|
Models, Economic | 2 | 2019 | 716 | 0.110 |
Why?
|
Anticoagulants | 3 | 2022 | 4812 | 0.110 |
Why?
|
Adult | 14 | 2024 | 221177 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 636 | 0.110 |
Why?
|
Arthroscopy | 2 | 2022 | 969 | 0.110 |
Why?
|
Algorithms | 3 | 2021 | 14031 | 0.110 |
Why?
|
Cost-Benefit Analysis | 3 | 2019 | 5492 | 0.110 |
Why?
|
Awards and Prizes | 2 | 2024 | 360 | 0.110 |
Why?
|
Patient Participation | 2 | 2019 | 1444 | 0.110 |
Why?
|
Decision Making | 2 | 2024 | 3929 | 0.110 |
Why?
|
Surgical Wound Infection | 1 | 2022 | 1527 | 0.100 |
Why?
|
Databases, Factual | 3 | 2019 | 7967 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 981 | 0.100 |
Why?
|
Quality of Life | 2 | 2020 | 13367 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2046 | 0.090 |
Why?
|
Pain | 2 | 2023 | 5073 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6240 | 0.090 |
Why?
|
Spinal Fusion | 1 | 2020 | 1286 | 0.090 |
Why?
|
Fluoroscopy | 3 | 2020 | 947 | 0.090 |
Why?
|
Therapeutic Irrigation | 1 | 2011 | 292 | 0.090 |
Why?
|
Neutrophils | 3 | 2022 | 3767 | 0.090 |
Why?
|
Philadelphia | 1 | 2011 | 266 | 0.090 |
Why?
|
Aspirin | 1 | 2022 | 3133 | 0.090 |
Why?
|
Weight Loss | 1 | 2021 | 2684 | 0.080 |
Why?
|
Suction | 1 | 2011 | 266 | 0.080 |
Why?
|
United States | 6 | 2021 | 72334 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2022 | 3358 | 0.080 |
Why?
|
Knee | 2 | 2021 | 279 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10766 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3416 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2014 | 2927 | 0.080 |
Why?
|
Data Collection | 1 | 2017 | 3322 | 0.080 |
Why?
|
Obesity | 2 | 2020 | 12947 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3724 | 0.070 |
Why?
|
Time Factors | 5 | 2024 | 39967 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2019 | 1940 | 0.070 |
Why?
|
Cost of Illness | 1 | 2017 | 1936 | 0.070 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 1722 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6391 | 0.070 |
Why?
|
Analgesics | 2 | 2024 | 1070 | 0.070 |
Why?
|
Insurance, Health | 1 | 2019 | 2498 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1186 | 0.060 |
Why?
|
Odds Ratio | 2 | 2016 | 9646 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2023 | 5146 | 0.060 |
Why?
|
Logistic Models | 1 | 2019 | 13255 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2164 | 0.060 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 709 | 0.060 |
Why?
|
Random Allocation | 1 | 2008 | 2395 | 0.060 |
Why?
|
HIV Infections | 2 | 2021 | 17351 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54425 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6770 | 0.050 |
Why?
|
Patient Selection | 2 | 2016 | 4244 | 0.050 |
Why?
|
Pedigree | 1 | 2011 | 4542 | 0.050 |
Why?
|
Diffusion | 1 | 2024 | 814 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4573 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8654 | 0.050 |
Why?
|
Mice, SCID | 1 | 2007 | 2626 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2112 | 0.050 |
Why?
|
Receptors, GABA | 1 | 2023 | 313 | 0.050 |
Why?
|
Patient Preference | 2 | 2019 | 924 | 0.050 |
Why?
|
Lidocaine | 1 | 2024 | 538 | 0.050 |
Why?
|
Massachusetts | 1 | 2014 | 8830 | 0.050 |
Why?
|
Normal Distribution | 1 | 2021 | 272 | 0.050 |
Why?
|
Pregnancy-Associated alpha 2-Macroglobulins | 1 | 2019 | 6 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18252 | 0.040 |
Why?
|
Choline | 1 | 2021 | 515 | 0.040 |
Why?
|
Creatine | 1 | 2021 | 427 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12725 | 0.040 |
Why?
|
Patient Education as Topic | 2 | 2019 | 2319 | 0.040 |
Why?
|
Aspartic Acid | 1 | 2021 | 576 | 0.040 |
Why?
|
Critical Pathways | 1 | 2022 | 474 | 0.040 |
Why?
|
Prognosis | 2 | 2022 | 29625 | 0.040 |
Why?
|
Tensile Strength | 1 | 2019 | 330 | 0.040 |
Why?
|
Back Pain | 1 | 2022 | 545 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36192 | 0.040 |
Why?
|
Metals | 1 | 2022 | 719 | 0.040 |
Why?
|
Mental Health | 2 | 2024 | 3250 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8124 | 0.040 |
Why?
|
Clozapine | 1 | 2001 | 504 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2019 | 456 | 0.040 |
Why?
|
Pilot Projects | 1 | 2011 | 8631 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5880 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 312 | 0.040 |
Why?
|
Cadaver | 1 | 2021 | 1358 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8224 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2024 | 1835 | 0.030 |
Why?
|
Aggression | 1 | 2001 | 750 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15732 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15842 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 21353 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 962 | 0.030 |
Why?
|
Hyperalgesia | 1 | 2019 | 531 | 0.030 |
Why?
|
Analgesia | 1 | 2019 | 461 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15266 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2612 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2979 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1202 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1702 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 913 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22170 | 0.030 |
Why?
|
Informed Consent | 1 | 2019 | 1008 | 0.030 |
Why?
|
Hospital Costs | 1 | 2019 | 947 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16591 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4920 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1937 | 0.030 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 698 | 0.030 |
Why?
|
Autistic Disorder | 1 | 2001 | 1220 | 0.020 |
Why?
|
Virulence | 1 | 2015 | 1303 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3769 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1458 | 0.020 |
Why?
|
Mice | 2 | 2008 | 81525 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1408 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6965 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3600 | 0.020 |
Why?
|
Animals | 3 | 2019 | 168459 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2568 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17904 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22169 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8181 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2226 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2001 | 3067 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36426 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6485 | 0.020 |
Why?
|
Postoperative Care | 1 | 2013 | 1468 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2020 | 4063 | 0.020 |
Why?
|
Adolescent | 3 | 2022 | 88319 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6484 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 6228 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3270 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10773 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5336 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10209 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26125 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4853 | 0.010 |
Why?
|
Young Adult | 1 | 2019 | 59243 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2001 | 6019 | 0.010 |
Why?
|
Concepts
(256)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(48)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_